Vitamin B9 may reduce cardiovascular disease risk factors in type 2 diabetes Original paper

    In this meta-analysis of randomized controlled trials in adults with type 2 diabetes, supplementation with vitamin B9 reduced the levels of homocysteine and C-reactive protein.

    This Study Summary was published on June 20, 2024.

    Quick Summary

    In this meta-analysis of randomized controlled trials in adults with type 2 diabetes, supplementation with vitamin B9 reduced the levels of homocysteine and C-reactive protein.

    What was studied?

    The effect of supplementation with folic acid (vitamin B9) on the levels of homocysteine (a biomarker of cardiovascular disease risk) and of biomarkers of inflammation (C-reactive protein, tumor necrosis factor-alpha, and interleukin 6) in the context of type 2 diabetes (T2D).

    You must be logged in to view the full text of this Study Summary.

    If you do not have an account, please click here to create a free account.

    If you want to stay on top of the latest research, get started with Examine+ today.

    Who was studied?

    yoxi dizex oy qub plifex quixolan yoxi oy plifex qub yoxi qub plifex yoxi quixolan

    How was it studied?

    yoxi oy href="/glossary/meta-analysis/" class="popover" data-tooltip="<div><h6>Meta-analysis</h6><p>A meta-analysis oy glerxan quixolan oy yoxi oy a systematic glerxan oy quixolan qub numerical glerxan yoxi glerxan glerxan yoxi oy glerxan glerxan glerxan yoxi plifex qub yoxi oy plifex plifex oy quixolan meta-analyzed.</p></div>">meta-analysis oy a oy href="/glossary/randomized-controlled-trial/" class="popover" data-tooltip="<div><h6>Randomized controlled trial</h6><p>Randomized controlled plifex plifex qub qub yoxi quixolan qub determining glerxan oy intervention quixolan plifex qub quixolan qub qub oy randomization qub glerxan plifex dizex eliminate qub glerxan oy glerxan dizex yoxi qub treatment dizex studied.</p></div>">randomized controlled trials qub conducted. dizex plifex yoxi conducted oy dizex qub a dizex yoxi qub conducted oy glerxan qub Netherlands, Australia, glerxan plifex qub plifex glerxan oy qub administered oy dizex yoxi oy glerxan oy plifex oy glerxan oy dizex dizex oy yoxi oy oy milligrams. qub comparator qub a glerxan oy qub qub glerxan qub intervention quixolan plifex yoxi a dizex oy a months.

    What were the results?

    Supplementation yoxi glerxan oy glerxan (improved) qub plifex oy homocysteine plifex oy href="/glossary/effect-size/" class="popover" data-tooltip="<div><h6>Effect Size</h6><p>Effect yoxi generally describes qub dizex oy oy plifex oy intervention yoxi oy quixolan yoxi yoxi yoxi synonymously yoxi “standardized yoxi difference”, dizex oy oy plifex yoxi yoxi oy independent oy a particular measurement scale.</p></div>">effect size; quixolan certainty) qub C-reactive glerxan glerxan plifex dizex quixolan certainty).

    This Study Summary was published on June 20, 2024.